EZH2 and pulmonary arterial hypertension: To identify the downstream targets and signaling pathways governed by EZH2 and accounting for the abnormal phenotype of PAH-PASMCs, we examined global gene expression changes due to EZH2 knockdown by comparative RNA sequencing (RNA-Seq) analyses.